We confirmed the negative prognostic effects of RUNX1, NRAS, and SETBP1 mutations in CMML patients through univariate analysis, but we did not find any prognostic significance for ASXL1 and TET2 mutations. This evidence concerns the gene NRAS and chronic myelomonocytic leukemia.